Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
McKesson
Mallinckrodt
Queensland Health
McKinsey
Express Scripts
Medtronic
QuintilesIMS
Moodys
Boehringer Ingelheim

Generated: February 23, 2018

DrugPatentWatch Database Preview

ROCEPHIN Drug Profile

« Back to Dashboard

When do Rocephin patents expire, and when can generic versions of Rocephin launch?

Rocephin is a drug marketed by Hoffmann La Roche and Roche and is included in five NDAs.

The generic ingredient in ROCEPHIN is ceftriaxone sodium; lidocaine. There are twenty-four drug master file entries for this compound. Additional details are available on the ceftriaxone sodium; lidocaine profile page.

US Patents and Regulatory Information for ROCEPHIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hoffmann La Roche ROCEPHIN ceftriaxone sodium INJECTABLE;INJECTION 062654-002 Apr 30, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hoffmann La Roche ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER ceftriaxone sodium INJECTABLE;INJECTION 050624-002 Feb 11, 1987 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hoffmann La Roche ROCEPHIN ceftriaxone sodium INJECTABLE;INJECTION 063239-002 Aug 13, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hoffmann La Roche ROCEPHIN ceftriaxone sodium INJECTABLE;INJECTION 050585-005 Dec 21, 1984 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hoffmann La Roche ROCEPHIN ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 050585-004 Dec 21, 1984 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche ROCEPHIN ceftriaxone sodium INJECTABLE;INJECTION 062510-003 Mar 12, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hoffmann La Roche ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER ceftriaxone sodium INJECTABLE;INJECTION 050624-003 Feb 11, 1987 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hoffmann La Roche ROCEPHIN KIT ceftriaxone sodium; lidocaine INJECTABLE;INJECTION 050585-007 May 8, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hoffmann La Roche ROCEPHIN ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 050585-002 Dec 21, 1984 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hoffmann La Roche ROCEPHIN ceftriaxone sodium INJECTABLE;INJECTION 063239-003 Aug 13, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
US Army
Baxter
Harvard Business School
Julphar
McKinsey
Healthtrust
Express Scripts
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot